Vident Advisory’s CME Group CME Stock Holding History

Vident Advisory’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.59M	Buy	22,298 +4,207	+23%	+$1.25M	0.06%	281
2025 Q4	$4.94M	Sell	18,091 -164	-0.9%	-$44.6K	0.05%	332
2025 Q3	$4.93M	Buy	18,255 +4,241	+30%	+$1.15M	0.05%	308
2025 Q2	$3.86M	Buy	14,014 +2,382	+20%	+$648K	0.04%	331
2025 Q1	$3.09M	Sell	11,632 -5,440	-32%	-$1.34M	0.05%	344
2024 Q4	$3.97M	Buy	17,072 +9,508	+126%	+$2.19M	0.07%	256
2024 Q3	$1.67M	Sell	7,564 -473	-6%	-$97.9K	0.04%	453
2024 Q2	$1.58M	Sell	8,037 -81,490	-91%	-$16.8M	0.04%	444
2024 Q1	$19.3M	Buy	89,527 +22,875	+34%	+$4.81M	0.4%	60
2023 Q4	$14M	Sell	66,652 -1,464	-2%	-$312K	0.35%	72
2023 Q3	$13.6M	Buy	+68,116	New	+$13.5M	0.42%	52

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vident Advisory's CME Position: Q1 2026 in Review

Vident Advisory increased its CME Group (CME) stake by 23% in Q1 2026, buying an estimated $1.25M and bringing the position to 22,298 shares worth $6.59M. The position accounts for 0.06% of the portfolio, ranked #281.

Vident Advisory first reported a position in CME in Q3 2023 and has held it in 11 quarters since. The position peaked at $19.3M in Q1 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Vident Advisory held 22,298 shares of CME Group worth $6.59M as of Q1 2026.
Vident Advisory bought 4,207 CME Group shares in Q1 2026, an estimated $1.25M.
CME Group made up 0.06% of Vident Advisory's portfolio in Q1 2026, its #281 holding.
Vident Advisory first reported a position in CME Group in Q3 2023 and has held it in 11 quarters since.
Vident Advisory's CME Group position peaked at $19.3M in Q1 2024.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.